HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Frank Schuster Selected Research

Halothane (Fluothane)

1/2014Functional and genetic characterization of clinical malignant hyperthermia crises: a multi-centre study.
1/2013A minimal-invasive metabolic test detects malignant hyperthermia susceptibility in a patient after sevoflurane-induced metabolic crisis.
4/2011In-vitro contracture testing for susceptibility to malignant hyperthermia: can halothane be replaced?
3/2010Minimally invasive metabolic testing for malignant hyperthermia susceptibility: a systematic review of the methodology and results.
1/2010Intramuscular injection of malignant hyperthermia trigger agents induces hypermetabolism in susceptible and nonsusceptible individuals.
2/2006The dose-response relationship and regional distribution of lactate after intramuscular injection of halothane and caffeine in malignant hyperthermia-susceptible pigs.
6/2005Inhibition of sarcoplasmic Ca2+-ATPase increases caffeine- and halothane-induced contractures in muscle bundles of malignant hyperthermia susceptible and healthy individuals.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Frank Schuster Research Topics

Disease

21Malignant Hyperthermia
03/2015 - 06/2005
9Contracture
01/2014 - 06/2005
2Acidosis
01/2014 - 11/2009
1Muscle Rigidity
01/2014
1Fever (Fevers)
01/2014
1Hypercapnia
01/2014
1Tachycardia (Tachyarrhythmias)
01/2014
1Anoxia (Hypoxia)
01/2014
1Hyperkalemia
01/2014
1Muscular Diseases (Myopathy)
01/2013
1Trismus (Lockjaw)
01/2013
1Vomiting
10/2012
1Nausea
10/2012
1Emery-Dreifuss Muscular Dystrophy (X-Linked Emery-Dreifuss Muscular Dystrophy)
01/2012
1Wounds and Injuries (Trauma)
12/2008
1Multiple Trauma (Multiple Injuries)
12/2008
1Postoperative Nausea and Vomiting (PONV)
12/2007

Drug/Important Bio-Agent (IBA)

7Halothane (Fluothane)FDA Link
01/2014 - 06/2005
7Succinylcholine (Suxamethonium Chloride)FDA LinkGeneric
01/2014 - 11/2009
6Caffeine (No Doz)FDA LinkGeneric
01/2014 - 06/2005
4CalciumIBA
01/2014 - 11/2009
3Anesthetics (Anesthetic Agents)IBA
01/2014 - 03/2010
3Dantrolene (Dantrium)FDA LinkGeneric
01/2013 - 10/2007
3sevoflurane (Ultane)FDA LinkGeneric
01/2013 - 10/2007
3Lactic AcidFDA LinkGeneric
01/2010 - 02/2006
2Carbon DioxideIBA
10/2007 - 02/2006
1Creatine Kinase (Creatine Phosphokinase)IBA
05/2013
1Inhalation AnestheticsIBA
01/2013
1Neuromuscular Depolarizing AgentsIBA
01/2013
1rocuronium (rocuronium bromide)FDA LinkGeneric
11/2012
1Ondansetron (Zofran)FDA LinkGeneric
10/2012
1Lamin Type A (Lamin A)IBA
01/2012
1Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
11/2011
1RyanodineIBA
11/2011
1Ofloxacin (Levofloxacin)FDA LinkGeneric
08/2011
1FluoroquinolonesIBA
08/2011
1Ciprofloxacin (Cipro)FDA LinkGeneric
08/2011
1MagnesiumIBA
05/2011
1Enflurane (Ethrane)FDA LinkGeneric
04/2011
1desflurane (I 653)FDA Link
04/2011
1IsofluraneFDA LinkGeneric
04/2011
1Neuromuscular Blocking AgentsIBA
03/2010
1Carbon MonoxideIBA
01/2010
1Dexamethasone (Maxidex)FDA LinkGeneric
12/2007
1Adenosine Triphosphatases (ATPase)IBA
06/2005
1cyclopiazonic acidIBA
06/2005

Therapy/Procedure

4Intramuscular Injections
01/2013 - 02/2006
3General Anesthesia
01/2014 - 01/2013
2Anesthesia
01/2014 - 01/2013
1Nebulizers and Vaporizers (Inhaler)
03/2015
1Intensive Care (Surgical Intensive Care)
01/2014
1Heart Transplantation (Grafting, Heart)
01/2012
1Resuscitation
12/2008